Varian Medical Systems (VAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
Cash Flows From Operating Activities | |||||
Net Income | 269,400 | 292,200 | 150,300 | 219,200 | 399,700 |
Depreciation Amortization | 98,900 | 93,000 | 72,700 | 76,900 | 79,800 |
Income taxes - deferred | 26,900 | 18,900 | 48,000 | -23,300 | -28,300 |
Accounts receivable | 35,200 | -111,700 | -76,100 | -18,000 | -167,700 |
Accounts payable and accrued liabilities | -66,900 | 49,700 | 21,900 | 5,500 | 9,700 |
Other Working Capital | 11,600 | -152,700 | 101,900 | -12,700 | -150,200 |
Other Operating Activity | 109,000 | 182,400 | 136,200 | 151,500 | 213,300 |
Operating Cash Flow | $484,100 | $371,800 | $454,900 | $399,100 | $356,300 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | 8,500 | -1,900 | -13,400 | 5,300 |
PPE Investments | -84,300 | -58,000 | -47,700 | -59,100 | -80,400 |
Net Acquisitions | -36,200 | -576,200 | -109,000 | -3,000 | -21,100 |
Purchase Of Investment | -26,300 | -32,800 | -10,100 | -8,400 | -600 |
Sale Of Investment | 9,200 | 29,900 | N/A | N/A | N/A |
Other Investing Activity | -2,700 | -3,100 | -6,000 | -46,500 | -12,400 |
Investing Cash Flow | $-140,300 | $-631,700 | $-174,700 | $-130,400 | $-109,200 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 110,500 | 636,500 | 503,300 | 231,000 | 83,000 |
Debt Repayment | N/A | -16,800 | N/A | N/A | N/A |
Common Stock Issued | 76,000 | 63,400 | 60,700 | 72,100 | 60,600 |
Common Stock Repurchased | -86,200 | -166,700 | -181,900 | -294,500 | -461,300 |
Other Financing Activity | -193,400 | -237,200 | -869,100 | -401,000 | 71,900 |
Financing Cash Flow | $-93,100 | $279,200 | $-487,000 | $-392,400 | $-245,800 |
Exchange Rate Effect | -9,000 | 8,400 | 4,700 | -3,900 | -3,300 |
Beginning Cash Position | 544,100 | 516,400 | 718,500 | 846,100 | 845,500 |
End Cash Position | 785,800 | 544,100 | 516,400 | 718,500 | 843,500 |
Net Cash Flow | $241,700 | $27,700 | $-202,100 | $-127,600 | $-2,000 |
Free Cash Flow | |||||
Operating Cash Flow | 484,100 | 371,800 | 454,900 | 399,100 | 356,300 |
Capital Expenditure | -84,300 | -58,000 | -47,700 | -59,100 | -80,400 |
Free Cash Flow | 399,800 | 313,800 | 407,200 | 340,000 | 275,900 |